IL6 and migraine disorder: CGRP may lead to the release of pro-inflammatory cytokines (Ray et al., 2021), and the levels of interleukine-6 (IL-6) and tumor necrosis factor alpha (TNF-α) were increased in the plasm of migraine patients (Ray et al., 2021).